 |
|
Treatment of Stage IVA Hepatocellular Carcinoma—Reply
Mircea Chirica, MD;
Olivier Scatton, MD;
Olivier Soubrane, MD
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
In reply
We thank Palavecino et al for their comments. As they pointed out, we reported outcomes of resection in patients with advanced HCC according to the fifth—instead of the sixth—edition of the AJCC/UICC staging classification. Although we agree that the new classification is overall more accurate, most of the recent publications reporting outcomes of surgery for advanced HCC refer to the fifth edition.1-3 For the sake of clarity, we chose to present our results according to the fifth edition of the AJCC/UICC staging classification to allow the comparison of our results with those of other reports.
The main goal of our study was to reappraise the place of surgery in patients with advanced HCC and not to validate the classification system. However, in our discussion, we did emphasize the limitations of the fifth edition of the AJCC/UICC staging classification in . . . [Full Text of this Article]
AUTHOR INFORMATION
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED ARTICLE
Treatment of Stage IVA Hepatocellular Carcinoma: Should We Reappraise the Role of Surgery?
Mircea Chirica, Olivier Scatton, Pierre-Philippe Massault, Thomas Aloia, Bruto Randone, Bertrand Dousset, Paul Legmann, and Olivier Soubrane
Arch Surg. 2008;143(6):538-543.
ABSTRACT
| FULL TEXT
RELATED LETTER
Treatment of Stage IVA Hepatocellular Carcinoma
Martin Palavecino, Christian Wittekind, and Jean Nicolas Vauthey
Arch Surg. 2008;143(12):1235-1236.
EXTRACT
| FULL TEXT
|
